Raspberry-Shaped Nanoparticle for Precise Drug Delivery RoySocChem drugdelivery raspberry nanoparticles nanomedicine
Dec 8 2022Reviewed by Megan Craig, M.Sc. An innovative method for improving the potency of available treatment has been published in the journal Nanoscale.
Shaffer and Zhai asked Tatyana Orlova and Maksym Zhukovskyi, two microscopy specialists at the Notre Dame Integrated Imaging Facility, for assistance in determining whether the dye had completely infused. Jordan Chasteen, a fellow doctoral student, continued the discussion by using a cancer drug to repeat the process. After conducting a number of tests, he was able to confirm that the cancer drug that had been loaded into the particles was still effective in killing cancer cells.
With a drug in the outer layer and a dye inside the “raspberry,” for example, the new particle’s distinctive structure could also allow for the loading of multiple ingredients, improving researchers’ ability to track how drugs release.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
How Ukraine crippled Putin’s war machine wiping out bombers, ships & bridgesUKRAINE has successfully wiped out much of Russia’s war machine, humiliating tyrant Putin with a series of precise strikes. While the Russian reported death toll approaches the 100,000 mark, …
Lire la suite »
Huge tornado hits Qatar as England trainsfor France World Cup quarter-finalA HUGE tornado has struck Qatar, with dramatic footage showing the black spiral-shaped storm clouds touching down in the desert country. The World Cup host has also been hit with torrential rain fo…
Lire la suite »
Interim analysis from a phase 2 randomized trial of EuCorVac-19: a recombinant protein SARS-CoV-2 RBD nanoliposome vaccine - BMC MedicineBackground Numerous vaccine strategies are being advanced to control SARS-CoV-2, the cause of the COVID-19 pandemic. EuCorVac-19 (ECV19) is a recombinant protein nanoparticle vaccine that displays the SARS-CoV-2 receptor-binding domain (RBD) on immunogenic nanoliposomes. Methods Initial study of a phase 2 randomized, observer-blind, placebo-controlled trial to assess the immunogenicity, safety, and tolerance of ECV19 was carried out between July and October 2021. Two hundred twenty-nine participants were enrolled at 5 hospital sites in South Korea. Healthy adults aged 19–75 without prior known exposure to COVID-19 were vaccinated intramuscularly on day 0 and day 21. Of the participants who received two vaccine doses according to protocol, 100 received high-dose ECV19 (20 μg RBD), 96 received low-dose ECV19 (10 μg RBD), and 27 received placebo. Local and systemic adverse events were monitored. Serum was assessed on days 0, 21, and 42 for immunogenicity analysis by ELISA and neutralizing antibody response by focus reduction neutralization test (FRNT). Results Low-grade injection site tenderness and pain were observed in most participants. Solicited systemic adverse events were less frequent, and mostly involved low-grade fatigue/malaise, myalgia, and headache. No clinical laboratory abnormalities were observed. Adverse events did not increase with the second injection and no serious adverse events were solicited by ECV19. On day 42, Spike IgG geometric mean ELISA titers were 0.8, 211, and 590 Spike binding antibody units (BAU/mL) for placebo, low-dose and high-dose ECV19, respectively (p | 0.001 between groups). Neutralizing antibodies levels of the low-dose and high-dose ECV19 groups had FRNT50 geometric mean values of 129 and 316, respectively. Boosting responses and dose responses were observed. Antibodies against the RBD correlated with antibodies against the Spike and with virus neutralization. Conclusions ECV19 was generally well-tolerated and induced antibodies
Lire la suite »
Evri says sorry for parcel delays in run-up to ChristmasThe delivery company says it's working to get orders out to customers complaining of long waits.
Lire la suite »
E-cargo bikes could soon be seen delivering across ShropshireE-cargo bikes could soon be seen making deliveries across Shrewsbury after the town council agreed to fund the use of the bikes.
Lire la suite »
'I think they're the cutest things'A BBC reporter finds out what the community think about the new delivery robots in Leeds.
Lire la suite »